8 research outputs found

    Epitope map.

    No full text
    <p>The figure shows the localization of known CD8 T cell epitopes specific of HCV (Panel <b>A</b>), HIV (Panel <b>B</b>) and IAV (Panel <b>C</b>). Epitopes are shown as blue segments underneath of the relevant proteins. IAV proteins that are encoded by the same RNA segment are shown in near proximity. CD8 T cell epitopes used in this work range from 9 to 10 residues and they all differ in at least one amino acid residue (See Material and Methods for details). Therefore, those epitopes that match in the same or near the same location are either epitope variants or overlapping epitopes.</p

    Correlation between epitope distribution and sequence conservation.

    No full text
    <p>For the proteomes of HCV (panel <b>A</b>), HIV (panel <b>B</b>) and IAV (panel <b>C</b>), we plot the ratio between observed and expected epitopes (Y-axis) against the corresponding conservation factors (<i>CF</i>)(X-axis).</p

    CD8 T Cell Epitope Distribution in Viruses Reveals Patterns of Protein Biosynthesis

    Get PDF
    <div><p>Distinguishing T cell epitope distribution patterns is relevant for epitope-vaccine design. To that end, we invest0069gated the distribution of known CD8 T cell epitopes from Hepatitis C Virus, Human Immunodeficiency Virus-1 and Influenza A Virus using χ<sup>2</sup> statistics. We found that epitopes are not distributed in the viral proteomes proportionally to the size of the source proteins. Specifically, capsid and matrix proteins pack significantly more epitopes than those expected by their size. Such non-homogeneous distribution cannot be accounted by underlying MHC I-peptide binding preferences nor it is related to sequence variability. Instead, we propose that it might be related to preferential protein translation/biosynthesis. Overall, these results support the prioritization of structural antigens for epitope identification and vaccine design.</p> </div

    Protein-size distribution of virus-specific CD8 T cell epitopes.

    No full text
    <p>We depict for each of the viral proteins of HCV, HIV and IAV the contribution (in percentage) to the χ<sup>2</sup> statistics (Panel <b>A</b>) and the ratio between observed and expected epitopes (Panel <b>B</b>). A value greater than 1 indicates more observed epitopes than expected, while a value lower than 1 reflects fewer epitopes than expected.</p

    Protein-size distribution of Gag-specific CD8 T cell epitopes.

    No full text
    <p>In panel <b>A</b>, we show the contribution of p17, p24, p7 and p6 to the Gag χ<sup>2</sup> statistics and in panel <b>B</b>, the ratio between observed and expected epitopes.</p

    Distribution of predicted A*0201-binding peptides in HIV.

    No full text
    <p>Only A*0201-bindig peptides from HIV were not distributed homogeneously by protein size at the α value (0.001) used in the epitope analysis. In panel <b>A</b>, we show the contribution (in percentage) to the χ<sup>2</sup> statistics of each HIV protein and in panel <b>B</b>, the ratio between observed and expected A*0201-binding peptides.</p

    Protein-size distribution of CD8 T cell epitopes in HCV, HIV and IAV.

    No full text
    <p>The expected epitopes in a given protein are those resulting after distributing all of the virus-specific epitopes proportionally to the length of that protein with regard to the total size of the relevant viral proteome.</p>*<p>Conservation Factor of each protein.</p

    χ<sup>2</sup>–statistics resulting of analyzing the distribution of MHC I-binding peptides in HCV, HIV and IAV.

    No full text
    *<p>Statistics obtained with sum of the peptides that are predicted to bind each MHC I molecule.</p
    corecore